These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5140523)

  • 1. Orally active cephaloglycin esters.
    Binderup E; Godtfredsen WO; Roholt K
    J Antibiot (Tokyo); 1971 Nov; 24(11):767-73. PubMed ID: 5140523
    [No Abstract]   [Full Text] [Related]  

  • 2. Cefazolin, a new semisynthetic cephalosporin antibiotic. 3. Absorption, excretion and tissue distribution in parenteral administration.
    Nishida M; Matsubara T; Murakawa T; Mine Y; Yokota Y; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1970 Apr; 23(4):184-94. PubMed ID: 5423363
    [No Abstract]   [Full Text] [Related]  

  • 3. Absorption, tissue concentration, and organ distribution of cefazolin.
    Ishiyama S; Nakayama I; Iwamoto H; Iwai S; Okui M
    Antimicrob Agents Chemother (Bethesda); 1970; 10():476-80. PubMed ID: 5521371
    [No Abstract]   [Full Text] [Related]  

  • 4. Cephaloglycin and its biologically active metabolite desacetylcephaloglycin.
    Wick WE; Wright WE; Kuder HV
    Appl Microbiol; 1971 Mar; 21(3):426-34. PubMed ID: 4994901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the metabolism of cephalosporins. I. The distribution and degradation of 7-[(1-14C)-3-chlorophenyl-acetamido]-cephalosporanic acid.
    Okui M; Hattori K; Nishida M
    J Antibiot (Tokyo); 1967 Sep; 20(5):287-92. PubMed ID: 5630772
    [No Abstract]   [Full Text] [Related]  

  • 6. Orally active 2-(alkyloxycarbonyl)-2-alkylideneethyl esters of cephalosporins.
    Hubschwerlen C; Charnas R; Angehrn P; Furlenmeier A; Graser T; Montavon M
    J Antibiot (Tokyo); 1992 Aug; 45(8):1358-64. PubMed ID: 1399857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Absorption, distribution and excretion of 14C-cefatrizine (14C-S-640 P) in rat (author's transl)].
    Matsuzaki M; Matsumoto H; Ochiai K; Tashiro Y; Hino M
    Jpn J Antibiot; 1976 Apr; 29(4):391-402. PubMed ID: 933333
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacologic studies with cefaclor, a new oral cephalosporin.
    Meyers BR; Hirschman SZ; Wormser G; Gartenberg G; Srulevitch E
    J Clin Pharmacol; 1978 Apr; 18(4):174-9. PubMed ID: 632363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cephradine absorption and excretion in fasting and nonfasting volunteers.
    Harvengt C; De Schepper P; Lamy F; Hansen J
    J Clin Pharmacol New Drugs; 1973 Jan; 13(1):36-40. PubMed ID: 4629988
    [No Abstract]   [Full Text] [Related]  

  • 10. Problems in the bio-assay of orally administered cephaloglycin in biological fluids and method for the detection of its metabolite, desacetylcephaloglycin.
    Shimizu K; Nishimura H
    J Antibiot (Tokyo); 1970 Apr; 23(4):216-22. PubMed ID: 4987304
    [No Abstract]   [Full Text] [Related]  

  • 11. Cefazolin, a new semisynthetic cephalosporin antibiotic. VI. Excretion and metabolism of cefazolin- 14 C in rats after intramuscular administration.
    Kozatani J; Okui M; Matsubara T; Nishida M
    J Antibiot (Tokyo); 1972 Feb; 25(2):86-93. PubMed ID: 5034810
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of therapeutic activity, of the secondary effects of blood and urinary levels of cephaloglycin by oral administration].
    Escárzaga Tapia E; Luna Castro M; González Díaz S; Gutiérrez Dávila M; Horta Sánchez C; Lozada L
    Rev Invest Clin; 1969; 21(1):35-47. PubMed ID: 5386523
    [No Abstract]   [Full Text] [Related]  

  • 13. [Detemination of cephalexin in serum, urine, bile, peritoneal exudate and bone marrow].
    Irmer W; Lubach D; Sucker U
    Dtsch Med Wochenschr; 1971 Mar; 96(11):464-8. PubMed ID: 5548186
    [No Abstract]   [Full Text] [Related]  

  • 14. [Organotropism of cephalexine in the rat].
    De Bernardi M; Roli M; De Bernardi G; Manzo L
    Boll Soc Ital Biol Sper; 1971 Jun; 47(12):363-5. PubMed ID: 5121635
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of ionization on absorption of cephalosporins.
    DeYoung JL; Tan HG; Huber HE; Zoglio MA
    J Pharm Sci; 1978 Mar; 67(3):320-3. PubMed ID: 25323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of cephalexin in adults and children].
    Simon C; Sievers G; Rohwedder HJ; Malerczyk V
    Dtsch Med Wochenschr; 1970 Oct; 95(42):2103-8. PubMed ID: 5475487
    [No Abstract]   [Full Text] [Related]  

  • 17. Absorption, distribution and excretion of SCE-963, a new broad-spectrum cephalosporin, in mice, rats, rabbits and dogs.
    Tsuchiya K; Kondo M; Kita Y; Noji Y; Takeuchi M; Fugono T
    J Antibiot (Tokyo); 1978 Dec; 31(12):1272-82. PubMed ID: 738967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of the distribution of semisynthetic cephalosporins in the body of rats].
    Iakovlev VP; Klimova VS; Rudzit EA
    Antibiotiki; 1979 Feb; 24(2):109-14. PubMed ID: 434800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of probenecid and food on the bioavailability of cephradine in normal male subjects.
    Mischler TW; Sugerman AA; Willard DA; Brannick LJ; Neiss ES
    J Clin Pharmacol; 1974; 14(11-12):604-11. PubMed ID: 4436447
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on absorption, distribution and excretion of cefadroxil (author's transl)].
    Esumi Y; Otsuki T; Nanpo T
    Jpn J Antibiot; 1979 Dec; 32(12):1350-5. PubMed ID: 529419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.